A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season

Thumbnail Image
Files
A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab.pdf(678.19 KB)
Date
2010
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
URI
https://repositorio.uc.cl/handle/11534/28442
 https://doi.org/10.1186/1471-2431-10-38
Collections
Artículos de revistas